Navigation Links
35th ESMO Congress media alert
Date:8/9/2010

Cancer is a leading cause of mortality worldwide, accounting for more than one in ten deaths. By 2030, the global burden is expected to exceed 12 million. The ESMO Congress provides a major international forum for the presentation of new research on the treatment of cancer

Congress Program Highlights

  • New findings from major Phase III trials, potentially practice changing
  • Promising new drugs to treat ovarian, skin, colorectal and other cancers
  • New hormonal agents in advanced prostate cancer
  • Personalized medicine: do ethnic differences matter?
  • Progress in the treatment of advanced colorectal cancer
  • Prevention and management of toxicity and other side-effects in targeted therapies
  • How proteomic profiling can guide therapy selection
  • The importance of conducting well-designed clinical trials
  • Combining chemotherapy and radiotherapy in small cell lung cancer
  • New developments in targeted therapies for lung cancer
  • MicroRNAs: the new genes involved in cancer
  • European disparities in cancer control
  • More than 200 presentations; more than 300 international experts
  • Late-breaking abstracts: the latest studies with new findings
  • NEW! Multidisciplinary Interactive Sessions (MIS): experts will present treatment options from the perspective of different disciplines within a multidisciplinary team.
  • Controversy sessions: five lively discussions on particularly hot topics based on latest research results.
  • Keynote Lectures: three important presentations in the field of basic science and translational research, the new frontier in cancer research.
  • The seventh batch of ESMO Designated Centers of Integrated Oncology and Palliative Care will be announced as centers of excellence for patient care in Europe.
  • A session on the newly released ESMO Clinical Practice Guidelines: the best standards of cancer care with improved methodology.
  • Oncology Highlights of the
    '/>"/>

Contact: Vanessa Pavinato
media@esmo.org
European Society for Medical Oncology
Source:Eurekalert

0

GOOD

Page: 1 2 3

Related biology news :

1. Biologists meet with members of Congress
2. The biology of fungi -- 1.5 million species -- 1 congress
3. NY state the focus of Congressional hearing on how research and innovation fuel local economies
4. 3rd Baltic Congress of Osteoporosis to take place in Riga
5. New FRAX tools launched at World Congress on Osteoporosis
6. Winner of Pierre Delmas Prize announced at World Congress on Osteoporosis 2010
7. Congress takes another stride toward public access to research
8. Record number of abstracts received for the World Congress on Osteoporosis 2010 -- IOF WCO-ECCEO10
9. World Congress on Osteoporosis 2010 -- IOF WCO -- ECCEO10
10. World Congress on Osteoporosis 2010 -- IOF WCO-ECCEO10
11. Register now online for the World Congress on Osteoporosis 2010 -- IOF WCO-ECCEO10
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2013)... A conference of 500 leading water scientists from around ... major reforms, "in the short span of one or ... on Earth will be living under the handicap of ... resource for which there is no substitute. This handicap ... , The scientists bluntly pointed to chronic underlying problems ...
(Date:5/23/2013)... , Automated conserved noncoding sequence (CNS) ... among grasses , Within the genome of each ... undergo little change in position and sequence over millions ... Some of these evolutionarily stable sequences, so-called conserved noncoding ... other genes or the condensation of chromosomes, but the ...
(Date:5/23/2013)... fruit, can be made both better-tasting and longer-lasting thanks ... "Working with GM tomatoes that are different to normal ... allows us to pinpoint exactly how to breed in ... Innes Centre. , The research could also lead to ... characteristics because even higher levels of the compounds can ...
Breaking Biology News(10 mins):A majority on Earth face severe self-inflicted water woes within 2 generations: Scientists 2A majority on Earth face severe self-inflicted water woes within 2 generations: Scientists 3A majority on Earth face severe self-inflicted water woes within 2 generations: Scientists 4Frontiers news briefs: May 23 2Frontiers news briefs: May 23 3The world's favorite fruit only better-tasting and longer-lasting 2
... the parareptiles, a diverse group of bizarre-looking terrestrial vertebrates ... small, slender, agile and lizard-like creatures, while others attained ... and bony spikes on their skulls. The researchers ... by the end-Permian extinction than at any other point ...
... exposure to bisphenol A (BPA) during pregnancy is associated ... from families without parental BPA exposure in the workplace, ... study is published in the current online issue ... was a greater magnitude of decrease in birth weight ...
... -- Experts agree that obesity prevention should begin before children ... data, health care providers often have trouble advising parents about ... soon to be published in The Journal of Pediatrics ... be an effective way to help prevent obesity. Dr. ...
Cached Biology News:Reptile 'cousins' shed new light on end-Permian extinction 2Parental exposure to BPA during pregnancy associated with decreased birth weight in offspring 2Parental exposure to BPA during pregnancy associated with decreased birth weight in offspring 3Study suggests prolonged bottle feeding increases the risk of obesity 2
(Date:5/24/2013)... and TEL AVIV, Israel , ... or the "Company") (NYSE MKT: NSPR), a leader in embolic ... the Company,s President and Chief Executive Officer, and ... participate in the Benchmark Company, LLC One-on-One Investor Conference on ... Wisconsin Ave., Milwaukee, WI. ...
(Date:5/24/2013)... DIEGO , May 24, 2013 ... company using proprietary taste science technologies to discover, develop, ... David Linemeyer , Ph.D., the Company,s Vice ... Vice President, Investor Relations & Corporate Communications, will present ... May 31, at 10:25 a.m. Eastern Time (7:25 a.m. ...
(Date:5/24/2013)... Dallas, Texas (PRWEB) May 24, 2013 ... web-based benchmarking survey on kinase profiling carried out ... data, details of the breakdown of the responses ... for the future (2015). It also highlights some ... Research survey groupings. Two bottom-up models were developed ...
(Date:5/24/2013)... (PRWEB) May 24, 2013 Many factors ... and uptake or efflux transporters at the blood-tissue barrier. ... related to unbound fractions in the tissue rather than ... these disposition challenges is required to guide lead optimization, ... identify any species-dependent variables that may impact the likely ...
Breaking Biology Technology:InspireMD To Participate In Benchmark Investor Conference On May 30th 2InspireMD To Participate In Benchmark Investor Conference On May 30th 3InspireMD To Participate In Benchmark Investor Conference On May 30th 4SENOMYX TO WEBCAST CORPORATE PRESENTATION AT THE CITI 2013 GLOBAL CONSUMER CONFERENCE 2Kinase Market Profiling - In House & Outsourced Trends 2015 Forecast in New Research Report at ReportsnReports.com 2Kinase Market Profiling - In House & Outsourced Trends 2015 Forecast in New Research Report at ReportsnReports.com 3Kinase Market Profiling - In House & Outsourced Trends 2015 Forecast in New Research Report at ReportsnReports.com 4DMPK for Targeted Tissue Delivery: Solutions for the Most Challenging Part of Outsourcing, New Life Science Webinar Hosted by Xtalks 2
... 40.8% to $11.6 million ... Net Income increased 118.8% to $2.5 million, ... Medicine,Corporation (OTC Bulletin Board: CHME) ("China Medicine" or ... and over-the-counter,pharmaceuticals, traditional Chinese medicines ("TCM"), nutritional and,dietary-supplements, ...
... has announced the,appointment of David A. Mann to the ... of the Board,s audit committee., "Dave,s years of ... sector are an invaluable asset to Omeros,",stated Gregory Demopulos, ... addition to our Board, and I expect that he ...
... VIEW, California, August 13 BN,ImmunoTherapeutics, Inc. ... the,National Cancer Institute (NCI) in the United ... (CRADA) the NCI and BN,ImmunoTherapeutics will jointly ... cancer. Under the CRADA, BN ImmunoTherapeutics has,rights ...
Cached Biology Technology:China Medicine Announces Strong Second Quarter 2008 Results 2China Medicine Announces Strong Second Quarter 2008 Results 3China Medicine Announces Strong Second Quarter 2008 Results 4China Medicine Announces Strong Second Quarter 2008 Results 5China Medicine Announces Strong Second Quarter 2008 Results 6China Medicine Announces Strong Second Quarter 2008 Results 7China Medicine Announces Strong Second Quarter 2008 Results 8China Medicine Announces Strong Second Quarter 2008 Results 9China Medicine Announces Strong Second Quarter 2008 Results 10China Medicine Announces Strong Second Quarter 2008 Results 11Omeros Appoints David A. Mann to its Board of Directors 2BN ImmunoTherapeutics Announces Partnership With National Cancer Institute 2BN ImmunoTherapeutics Announces Partnership With National Cancer Institute 3